P12499 (POL_HV1Z2) Human immunodeficiency virus type 1 group M subtype D (isolate Z2/CDC-Z34)(HIV-1)
Gag-Pol polyprotein UniProtKBInterProInteractive Modelling
1436 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
32 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structures of HLA-A*1101 in complex with immunodominant nonamer and decamer HIV-1 epitopes clearly … |
Heteromer P04439; P61769; | |||||
| Assess | ||||||
| Crystal Structure of HLA-A2 Bound to LIR-1, a Host and Viral MHC Receptor |
Heteromer P04439; P61769; Q8NHL6; | |||||
| Assess | ||||||
| Nonstandard peptide binding of HLA-B*5101 complexed with HIV immunodominant epitope KM2(TAFTIPSI) |
Heteromer P01889; P61769; | |||||
| Assess | ||||||
| Crystal structure of HLA-B*5201 in complexed with HIV immunodominant epitope (TAFTIPSI) |
Heteromer P01889; P61769; | |||||
| Assess | ||||||
| HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment 1F1 in the outsid… | homo-2-mer | 3×BME; 1×1F1; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of (G16C/L38C) HIV-1 Protease in Complex with DRV | homo-2-mer | 1×017; 1×ACT; | ||||
| Assess | ||||||
| HIV Protease (PR) dimer with inhibitor TL-3 bound and fragment 1F1 in the outside/top of flap | homo-2-mer | 1×3TL; 2×BME; 1×1F1; | ||||
| Assess | ||||||
| Crystal Structure of wild-type HIV-1 Protease in Complex with DRV | homo-2-mer | 2×EDO; 1×017; 1×PO4; 1×DMS; | ||||
| Assess | ||||||
| HIV protease (PR) dimer with acetate in exo site and peptide in active site | homo-2-mer | 4×DMS; 1×ACT; 10×GOL; 1×BME; | ||||
| Assess | ||||||
| Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) | homo-2-mer | 3×CL; 1×C7J; | ||||
| Assess | ||||||
| HIV-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-State Mimic with Improved… | homo-2-mer | 1×5AH; | ||||
| Assess | ||||||
| HIV Protease (PR) with inhibitor TL-3 bound, and DMSOs in exo site | homo-2-mer | 2×3TL; 6×DMS; 2×BME; | ||||
| Assess | ||||||
| HIV Protease (PR) with inhibitor TL-3 and fragment hit 4D9 by soaking | homo-2-mer | 1×3TL; 1×4DX; 4×DMS; 2×K; 1×BME; | ||||
| Assess | ||||||
| Crystal Structure of (R14C/E65C) HIV-1 Protease in complex with DRV | homo-2-mer | 1×017; 1×GOL; | ||||
| Assess | ||||||
| HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment 1F1-N in the outs… | homo-2-mer | 1×IOP; | ||||
| Assess | ||||||
| HIV-1 PROTEASE DIMER COMPLEXED WITH A-84538 | homo-2-mer | 1×RIT; | ||||
| Assess | ||||||
| HIV Protease (PR) dimer with inhibitor TL-3 bound and fragment 2F4 in the outside/top of flap | homo-2-mer | 1×3TL; 3×DMS; 2×BME; 1×2FX; | ||||
| Assess | ||||||
| HIV Protease with fragment 4D9 bound | homo-2-mer | 1×3TL; 1×4DX; 3×DMS; 2×K; 1×BME; | ||||
| Assess | ||||||
| HIV-1 PROTEASE DIMER COMPLEXED WITH A-98881 | homo-2-mer | 1×A88; | ||||
| Assess | ||||||
| TL-3 inhibited Trp6Ala HIV Protease with 3-bromo-2,6-dimethoxybenzoic acid bound in flap site | homo-2-mer | 6×NO3; 1×BME; 2×DMS; 1×3TL; 3×06B; | ||||
| Assess | ||||||
| HIV-1 Inhibitors with a Tertiary-Alcohol-containing Transition-State Mimic and various P2 and P1 pr… | homo-2-mer | 1×G40; | ||||
| Assess | ||||||
| TL-3 inhibited Trp6Ala HIV Protease with 1-bromo-2-napthoic acid bound in exosite | homo-2-mer | 1×DMS; 2×27B; 5×NO3; 1×3TL; 1×BR; | ||||
| Assess | ||||||
| HIV-1 Protease Inhibitors Containing a Tertiary Alcohol in the Transition-State Mimic with Improved… | homo-2-mer | 1×5AH; | ||||
| Assess | ||||||
| Crystal Structure of (G16A/L38A) HIV-1 Protease in Complex with DRV | homo-2-mer | 1×017; 2×SO4; 1×EDO; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of (G16C/L38C) HIV-1 Protease in Complex with DRV | homo-2-mer | 1×017; 1×GOL; 2×PO4; | ||||
| Assess | ||||||
| HIV-1 Inhibitors with a Tertiary-Alcohol-containing Transition-State Mimic and various P2 and P1 pr… | homo-2-mer | 1×CXG; | ||||
| Assess | ||||||
| TL-3 inhibited Trp6Ala HIV Protease | homo-2-mer | 1×NO3; 1×3TL; | ||||
| Assess | ||||||
| Apo HIV Protease (PR) dimer in closed form with fragment 1F1 in the outside/top of flap | homo-2-mer | 5×DMS; 4×EDO; 1×1F1; | ||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 HEXAGONAL FORM | homo-2-mer | 1×BAY; | ||||
| Assess | ||||||
| HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 ORTHORHOMBIC FORM | homo-2-mer | 1×BAY; | ||||
| Assess | ||||||
| Apo HIV Protease (PR) dimer in closed form with fragment 1F1-N in the outside/top of flap | homo-2-mer | 1×PEG; 2×DMS; 4×GOL; 1×IOP; | ||||
| Assess | ||||||
| Crystal Structure of apo(G16C/L38C) HIV-1 Protease | homo-2-mer | 1×HGU; 3×GOL; 1×OXY; 1×ACT; 1×PO4; | ||||
| Assess | ||||||
9 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6rwm.1.A | homo-12-mer | 0.75 | 8×ZN; | 76.39 | ||
| Assess | ||||||
| 6rwl.1.A | monomer | 0.73 | 1×ZN; | 76.39 | ||
| Assess | ||||||
| 6rwl.1.B | monomer | 0.73 | 1×ZN; | 76.39 | ||
| Assess | ||||||
| 6v3k.3.A | homo-4-mer | 0.71 | 93.23 | |||
| Assess | ||||||
| 7t15.1.E | homo-6-mer | 0.70 | 83.98 | |||
| Assess | ||||||
| 7sep.1.A | homo-2-mer | 0.70 | 95.14 | |||
| Assess | ||||||
| 1l6n.1.A | monomer | 0.70 | 91.17 | |||
| Assess | ||||||
| 5u1c.1.A | homo-4-mer | 0.68 | 90.48 | |||
| Assess | ||||||
| 8fzc.1.P | homo-18-mer | 0.65 | 69.68 | |||
| Assess | ||||||